Thursday, February 19, 2026 5:40:55 PM
HGILS, I just listened to the CC. I really don't care what happens with M & A or with up listing. Really, I don't care.
Why don't I care~?
Elite's balance sheet says it all.
After just 3 quarters and already over $100 million in revenues. They (management) already know the what the final Q will bring. Always one Q behind when reporting.
NH has this small Pharma performing very well.
The anti-coagulant may or may not be. Still waiting for the Courts or Purdue for generic OxyContin.
R&D still chugging along. It's all good.
And STILL the share price gets pushed DOWN~! Revenues up over 117% from this Q last year~? And as Carter pointed out all 3 quarters have been outperforming what was expected with the lowest in the 90% range, the other over 100%.
The manipulation isn't just because Elite is on the OTC either. Lots of manipulation going on throughout the market on all exchanges.
One should never be influenced by SHORTS. Spoofing is here there and everywhere. Pay ZERO attention to these clowns.
All one has to do is look at the balance sheet. That's it~!
This is like Elite being at $0.03 again. Good luck keeping this filly in the barn.
It's all good HGILS.
$ELTP baby~!
Why don't I care~?
Elite's balance sheet says it all.
After just 3 quarters and already over $100 million in revenues. They (management) already know the what the final Q will bring. Always one Q behind when reporting.
NH has this small Pharma performing very well.
The anti-coagulant may or may not be. Still waiting for the Courts or Purdue for generic OxyContin.
R&D still chugging along. It's all good.
And STILL the share price gets pushed DOWN~! Revenues up over 117% from this Q last year~? And as Carter pointed out all 3 quarters have been outperforming what was expected with the lowest in the 90% range, the other over 100%.
The manipulation isn't just because Elite is on the OTC either. Lots of manipulation going on throughout the market on all exchanges.
One should never be influenced by SHORTS. Spoofing is here there and everywhere. Pay ZERO attention to these clowns.
All one has to do is look at the balance sheet. That's it~!
This is like Elite being at $0.03 again. Good luck keeping this filly in the barn.
It's all good HGILS.
$ELTP baby~!
Bullish
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
